SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is capturing significant community attention as a brand-driven project focusing on organic, community-led product initiatives and IRL events. Supporters emphasize the project's consistent building efforts, widespread merchandise, and the conviction of its members as key drivers for long-term growth across multiple chains.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crow with knife community is actively celebrating the project's two-year anniversary while highlighting its multi-chain presence and deflationary tokenomics. Investors remain vocal about upcoming developments and the strength of their organic, community-driven approach.

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate Inc. is trending as investors aggressively accumulate shares in anticipation of critical upcoming catalysts, including imminent U.S. patent news and a final FDA approval decision scheduled for May 31, 2026. The community sentiment is highly optimistic, with many citing the company's proprietary Precision Timed Release technology as a potential game-changer in the massive ADHD market and debating the prospects of a strategic partnership or buyout.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin (XCN) is currently experiencing heightened community engagement and price volatility as traders closely monitor the upcoming Goliath mainnet launch. While some investors remain optimistic about the project's roadmap and potential for real-world asset tokenization, others are expressing skepticism and caution due to historical price trends and persistent concerns regarding transparency.

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Clene Inc

Clene Inc. is trending as investors aggressively position themselves ahead of a pivotal regulatory milestone, with the community closely tracking the expected submission of an NDA for accelerated approval in ALS. Enthusiastic sentiment is fueled by anticipation of upcoming clinical biomarker data and the potential for a significant re-rating, though some investors remain cautious about the company's cash runway and the history of volatility surrounding speculative biotech catalysts.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently trending as investors monitor ongoing discussions with the FDA regarding the clinical hold on its Phase 3 MAGNITUDE trials. The community is actively debating the stock's high short interest and the potential for a rapid recovery, with many focused on the upcoming clinical data readouts as a key catalyst.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is trending as traders attempt to hedge against geopolitical instability in the Middle East, with community discussion intensely focused on whether current volatility levels accurately reflect potential supply chain disruptions and oil price shocks. Investors remain divided, debating whether this is a genuine hedge for a broader market correction or a 'widowmaker' trap subject to structural decay that favors short-term scalping over long-term holding.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is drawing significant investor interest as the company shifts from recent margin-related volatility to a narrative of robust backlog growth and expanding data center demand, buoyed by positive analyst upgrades and a record-high order intake. The community is actively debating the company's potential as a critical infrastructure play for AI-driven power needs, with many focusing on whether recent operational improvements will finally bridge the gap between their massive project pipeline and sustained profitability.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor is seeing significant momentum as investors digest the upcoming mid-December halving event and Grayscale's recent Form 10 filing for a spot TAO ETF. The community remains highly focused on the project's decentralized AI infrastructure, with active discussions centered on subnet performance and long-term scarcity comparisons to Bitcoin.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin (CRO) is gaining attention as investors weigh its potential for a rally driven by recent institutional partnerships and ongoing developments within the Cronos ecosystem. The community remains divided between long-term bulls anticipating a breakout from recent consolidation and skeptics frustrated by the token's performance relative to broader market momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
